PeproTech), 1% nonessential amino acids and penicillin/streptomycin. Heavy MEF-conditioned medium was harvested daily for 7 consecutive days (first batch discarded) and re-supplemented with 4 ng/ml bFGF after each collection. Growing the hESC for 1 wk (~5 population doublings)
(Invitrogen), 100 µM β-mercaptoethanol, 4 ng/ml basic fibroblast growth factor (bFGF; PeproTech), 1% nonessential amino acids and penicillin/streptomycin. Heavy MEF-conditioned medium was harvested daily for 7 consecutive days (first batch discarded) and re-supplemented with 4 ng/ml bFGF after each collection. Growing the hESC for 1 wk (~5 population doublings) in the heavy MEF-conditioned medium resulted in complete labeling of the cells with the heavy stable isotopes.
In Solution Digestion
Harvested cells were washed with PBS and subsequently lysed using a solution of 25 mM ammonium bicarbonate and 8 M urea, pH 8.2, containing 10 mM potassium phosphate, 5 mM sodium fluoride and 5 mM sodium orthovanadate. Following, cellular debris was pelleted by centrifugation for 20 min at 13,000 rpm. Aliquots of each time point were separated onto a SDS-PAGE gel. The protein concentration was determined after Coomassie brilliant blue staining using GelCode (Pierce). Subsequently proteins extracts were mixed in a 1:1 ratio and reduced and alkylated using 5 mM DTT and 10 mM iodoacetamide. Five μg LysC (Roche Diagnostics GmbH, Mannheim, Germany) was added and the mixture was incubated for 4 h at room temperature. Following the mixture was diluted 4-fold to lower the urea concentration to 2 M and 20 μg modified sequencing grade trypsin (Roche Diagnostics GmbH, Mannheim, Germany) was added for further digestion overnight at 37ºC. Prior to strong cation exchange fractionation, peptides were extracted and desalted using a small bed of Aqua C 18 , 5 μm, 200 Å, (Phenomenex, Torrance, CA, USA) material in a constricted pipet tip. In short, a small plug of C 18 material (3M Empore C 18 extraction disk) was placed into a GELoader tip (Eppendorf) similar to what has been previously described (Rappsilber et al., 2003) , onto which ~10 μl (bed-volume) Aqua C 18 material was placed. The solution digest (~400 μl) was loaded onto the column, which was subsequently washed 3 times with 20 μl 0.1% formic acid. Peptides were eluted with 40 μl 80% acetonitrile, 0.1% formic acid. The eluate was dried completely and subsequently reconstituted in
Strong Cation Exchange
Strong cation exchange was performed using two in-line coupled Zorbax BioSCX-Series II columns (Agilent Technologies, Amstelveen, The Netherlands; 0.8 mm ID × 50 mm L, 3.5 µm), a FAMOS autosampler (LC-packing, Amsterdam, The Netherlands) and a Shimadzu LC-9A binary pump and a SPD-6A UV-detector (Shimadzu, Tokyo, Japan). After injection, the first 5 min were ran isocratic at 100% solvent A (20% acetonitrile, 0.05% formic acid, pH 3.0), followed by a linear gradient of 1% min -1 solvent B (500 mM KCl in 20% acetonitrile and 0.05% formic acid, pH 3.0). A total of 24 SCX fractions (1 min each, i.e. 50 μl elution volume) were manually collected and dried in a vacuum centrifuge.
2D-nanoflow-HPLC
A home-built nanoflow vented column system, comprising of a LC-Packings Ultimate quaternary solvent delivery system, a thermostatted FAMOS autosampler and a Switchos 6-Port switching module (LC-Packings, Amsterdam, The Netherlands), coupled on-line to a LTQ-Orbitrap mass spectrometer (Thermo Electron, Bremen, Germany), was used for all analyses (for detail see (Meiring et al., 2002; Pinkse et al., 2008) ). The bi-phasic trap column consist of three separate pre-columns; a 30 mm L × 100 μm ID Aqua C 18 precolumn, followed by a 5 mm L × 100 μm ID TiO 2 precolumn, followed by another 30 mm L × 100 μm ID Aqua C 18 precolumn. This Peptides from each SCX fraction were reconstituted in 20 μl 5% formic acid, which were injected onto the sandwich precolumn at 3 µl/min. In this stage the majority of peptides will bind to the initial C 18 precolumn. After 10 min of trapping, the switching valve was turned, thereby blocking the waste outlet in between trapping and analytical column and opening the splitter before the 'sandwich'-precolumn column. The flow was increased to 400 μl/min (backpressure ~200 bar), which leads to a precolumn/analytical column flow of ~100 nl/min. Using a linear H 2 O/MeCN gradient peptides trapped on the first C 18 precolumn are eluted and separated. In this stage phosphorylated peptides are trapped onto the 5 mm L TiO 2 precolumn, all other peptides, with no TiO 2 affinity are chromatographically separated at ~100 nl/min in a 100-min gradient from 0 to 40% solvent B. Elution of phosphorylated peptides is achieved by injection of 30 µl 250 mM ammonium hydrogen bicarbonate, pH 9.0 (adjusted with ammonia) containing 10 mM sodium phosphate, 5 mM sodium orthovanadate and 1 mM potassium fluoride. The flow for elution was 3 µl/min and the duration was 20 min. After this, 20 μl 5% formic acid was injected also at a flow of 3 µl/min and the duration was 10 min. During these two steps, phosphorylated peptides are eluted from the TiO 2 precolumn and subsequently trapped onto the second C 18 precolumn and the TiO 2 precolumn is at the same time regenerated. Finally, a second H 2 O/MeCN gradient was ran to separate the phosphopeptides. The column effluent was electrosprayed (1.6-1.8 kV) via distal coated emitter tips (New Objective), butt-connected to the analytical column.
An additional 33 MΏ resistor was placed between the high voltage power supply and the electrospray needle in order to reduce ion current.
Mass Spectrometry
The LTQ-Orbitrap mass spectrometer was operated in positive ionization, data dependent mode, automatically switching between MS and MS/MS. Full scan MS spectra (from m/z 400-1,500)
were acquired in the Orbitrap with a resolution of 60,000 at m/z 400 after accumulation to target value of 500,000. The three most intense ions at a threshold above 5,000 were selected for collision-induced fragmentation in the linear ion trap at normalized collision energy of 35% after accumulation to a target value of 10,000.
Western Blot
Aliquots of the cell samples in 8 M urea were diluted to 1 M and boiled in 5× Laemmli sample buffer. Equal protein amounts of each sample were separated by SDS-PAGE and assessed by
Coomassie brilliant blue staining using GelCode (Pierce). Western blotting using mouse anti-OCT4 (Cat#sc-5279, SantaCruz) at 1:400, rabbit-anti SOX2 (Cat#AB5603, Chemicon) at 1:1,000, rabbit anti-phospho-4EIFEBP1 (T37/T46) (Ca#9459, Cell Signaling Technology) at 1:1,000, goat anti-phospho-GSK3alpha/beta (Y279/Y216) (Cat#sc-11758, Santa Cruz) at 1:500, mouse anti-beta-Actin (Cat#A5441, from Sigma) at 1:5,000, or rabbit anti-SUMO2/3 (Cat#AV-SM23-0100; (Vertegaal et al., 2004) ) at 1:1,000 was carried out as previously (Van Hoof et al., 2006) .
(Quantitative) Immunofluorescence
Cells were on glass coverslips and fixed in 4% PFA for 30 min, permeabilized for 1 min. with 0.1% Triton X-100 in PBS and blocked with 4% serum in PBS for 1 h. Cells were incubated for 1 h at RT with goat anti-phospho-GSK3alpha/beta (Y279/Y216) (Cat#sc-11758, Santa Cruz) at 1:100 or anti-c-Myc (Cat#sc-40, SantaCruz) as described previously (Van Hoof et al., 2006 
Computational Analysis
Protein classification was performed using Panther (Mi et al., 2007) (www.pantherdb.org).
BinGO 2.0 (Maere et al., 2005) a plugin for Cytoscape (Shannon et al., 2003) was used for the enrichment analysis of gene ontology categories. NetworKIN (Linding et al., 2007) and NetPhorest (Miller et al., 2008) algorithms were used to predict potential kinases for every phosphorylation site identified in our study. Phosphopeptide measured ratios were log 2 transformed, normalized and clustered with Spotfire (http://spotfire.tibco.com/) into seven categories by using the k-means algorithm with the Pearson correlation distance. Text mining was performed using Anni 2.0 (http://www.biosemantics.org) by clustering proteins by cooccurrence in Medline (Jelier et al., 2008) . ) and differentiating cells were subjected to SDS-PAGE, followed by Western blotting using antibodies against OCT4 or SOX2. Loading of equal amounts of protein for each sample was verified by staining of a gel with GelCode.
SUPPLEMENTAL TABLE

FIGURE S2 Figure S2. Ratios of Mono-, Di-, and Multiply-phosphorylated Peptides
The identified phosphopeptides in our study were distributed based on the number of phosphosites and compared with those obtained from two other phosphoproteomic studies (Olsen et al., 2006; Villen et al., 2007) . This mainly reflects differences in the experimental approach due to the use of online TiO2 (Van Hoof et al.) , offline TiO2/DHB (Olsen et al.) or IMAC (Villen et al.) . Furthermore, it shows that TiO2-based approaches are biased towards monophosphorylated peptide enrichment (Thingholm et al., 2008) . 
FIGURE S4 Figure S4. Functional Comparison between Undifferentiated and Differentiated Proteomes
Proteomes of undifferentitated and differentiated hESC (HES-2) reported previously (Van Hoof et al., 2006) were classified by molecular function using Panther (Mi et al., 2007) . The Pearson's chi-square test was used for statistical analysis. * denotes P<0.05. proteins were reported to be silenced genes (K27) as described in Pan et al. (Pan et al., 2007) .
Due to overlapping genes reported with two different types of marks, only those uniquely modified with one type were used for this comparison. Kinases responsible for the hESC phosphoproteome and Phospho.ELM (Diella et al., 2004) and PhosphoSite were predicted by NetworKIN (Linding et al., 2007) and NetPhorest (Miller et al., 2008) algorithms. The percentage of substrates for every predicted kinase was compared between these two data sets. Kinases with low incidence (<0.5% substrates) were removed to simplify the figure. The Pearson's chi-square test was used for statistical analysis. * denotes P<0.0001.
